GSLC:LSE:LSE-Goldman Sachs ActiveBeta US Large Cap Equity UCITS ETF USD Acc (USD)

ETF | Others |

Last Closing

USD 83.175

Change

+0.66 (+0.80)%

Market Cap

USD 0.14B

Volume

12.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-28.00 (-12.84%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+1.10 (+0.80%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.08 (+0.46%)

USD 581.04B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.32%)

USD 581.04B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.25 (-0.39%)

USD 266.08B
0QZO:LSE 0QZO

+1.20 (+1.12%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.16 (+0.56%)

USD 239.13B
0QZ3:LSE Qualcomm Inc.

+1.52 (+0.92%)

USD 202.26B
0R24:LSE Intel Corp.

-0.28 (-1.26%)

USD 196.14B

ETFs Containing GSLC:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.80% 56% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.80% 56% F 56% F
Trailing 12 Months  
Capital Gain 24.67% 82% B 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.67% 80% B- 78% C+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 14.10% 76% C+ 76% C+
Dividend Return 14.10% 75% C 75% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.80% 56% F 72% C
Risk Adjusted Return 110.17% 94% A 96% N/A
Market Capitalization 0.14B 55% F 31% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike